Robert Hromas Selected Research

Metals

2/2012

Cytotoxic activity of the titanium alkoxide (OPy)(2)Ti(4AP)(2) against cancer colony forming cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert Hromas Research Topics

Disease

37	Neoplasms (Cancer) 03/2024 - 10/2005
5	Genomic Instability 12/2022 - 01/2011
5	Leukemia 11/2021 - 08/2002
5	Genetic Translocation (Chromosomal Translocation) 01/2019 - 07/2010
4	Breast Neoplasms (Breast Cancer) 10/2023 - 01/2009
3	Infections 01/2021 - 12/2005
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 02/2012
2	Glioblastoma (Glioblastoma Multiforme) 12/2021 - 01/2019
2	Glioma (Gliomas) 12/2021 - 01/2019
2	Fanconi Anemia (Fanconi's Anemia) 12/2020 - 01/2019
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2005 - 10/2005
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2023
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2023
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023
1	Bone Resorption 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Osteosarcoma (Osteogenic Sarcoma) 01/2022
1	Crohn Disease (Crohn's Disease) 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021
1	Ulcerative Colitis 01/2021
1	Celiac Disease (Celiac Sprue) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	Drug-Related Side Effects and Adverse Reactions 12/2019
1	Thrombocytopenia (Thrombopenia) 12/2019
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Bone Marrow Failure Disorders 01/2019
1	Malignant Mesothelioma 10/2017
1	Carcinoma (Carcinomatosis) 01/2016
1	Colorectal Neoplasms (Colorectal Cancer) 01/2015
1	Colonic Neoplasms (Colon Cancer) 07/2013
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 04/2013

Drug/Important Bio-Agent (IBA)

16	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 12/2005
11	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2011
4	DT2216IBA 01/2023 - 12/2019
4	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2023 - 03/2014
3	snake venom protein C activatorIBA 03/2024 - 12/2019
3	Histones (Histone)IBA 10/2023 - 01/2011
3	Proteolysis Targeting ChimeraIBA 01/2022 - 01/2020
3	Antineoplastic Agents (Antineoplastics)IBA 12/2019 - 01/2011
2	UbiquitinIBA 10/2023 - 01/2022
2	Ligases (Synthetase)IBA 10/2023 - 01/2020
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 10/2023 - 01/2022
2	Apoptosis Regulatory ProteinsIBA 01/2023 - 01/2023
2	navitoclaxIBA 12/2021 - 12/2019
2	Chemokine CCL21IBA 01/2021 - 08/2002
2	ChemokinesIBA 01/2021 - 08/2006
2	Poly (ADP-Ribose) Polymerase-1IBA 01/2019 - 05/2013
2	EndonucleasesIBA 11/2017 - 03/2014
2	A-Form DNA (A-DNA)IBA 05/2013 - 06/2011
2	TransposasesIBA 07/2010 - 05/2010
2	trioctyl phosphine oxide (TOPO)IBA 01/2009 - 10/2008
1	(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA 01/2023
1	Bcl-2-Like Protein 11IBA 01/2023
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2023
1	Mitogen-Activated Protein KinasesIBA 01/2023
1	butyl phosphorotrithioate (DEF)IBA 12/2022
1	olaparibIBA 01/2022
1	carbazoleIBA 01/2022
1	Estrogen ReceptorsIBA 01/2022
1	Annexin A5IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Gemcitabine FDA Link 01/2022
1	Immune Checkpoint ProteinsIBA 01/2022
1	talazoparibIBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	RNA Demethylase AlkB Homolog 5IBA 01/2022
1	6-methyladenineIBA 01/2022
1	CrizotinibIBA 12/2021
1	Neutralizing AntibodiesIBA 12/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Fanconi Anemia Complementation Group D2 ProteinIBA 12/2020
1	Discoidin Domain ReceptorsIBA 06/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	IonsIBA 01/2019
1	Protons (Proton)IBA 01/2019
1	Proto-Oncogene Proteins c-metIBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	CarbonIBA 01/2019
1	Complementary DNA (cDNA)IBA 11/2017
1	Adenosine (Adenocard)FDA LinkGeneric 01/2016
1	RibonucleotidesIBA 01/2016
1	AICA ribonucleotide (ZMP)IBA 01/2016
1	Phosphates (Orthophosphate)IBA 01/2016
1	NSC666715IBA 01/2015
1	Temozolomide (Temodar)FDA LinkGeneric 01/2015
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2015
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 03/2014
1	SmokeIBA 04/2013
1	QuinolonesIBA 12/2012
1	Ciprofloxacin (Cipro)FDA LinkGeneric 12/2012
1	PlatinumIBA 02/2012

Therapy/Procedure

15	Therapeutics 03/2024 - 08/2002
9	Drug Therapy (Chemotherapy) 01/2022 - 10/2005
5	Radiotherapy 01/2023 - 10/2017
2	Aftercare (After-Treatment) 01/2023 - 12/2005
1	Transplantation 01/2023
1	Immunotherapy 01/2022